Cathay International Holdings Ld Change Of Director
12 October 2018 - 8:31PM
RNS Non-Regulatory
TIDMCTI
Cathay International Holdings Ld
12 October 2018
Cathay International Holdings Limited
("Cathay" or the "Company")
Resignation of Director at Cathay's subsidiary Lansen
Hong Kong, 12 October 2018 - Cathay International Holdings
Limited (LSE: CTI.L), an operator and investor in the growing
healthcare sector in the People's Republic of China (the "PRC"),
announces that Lansen Pharmaceutical Holdings Limited ("Lansen")
(HKEX: 503), the Company's 50.56% owned subsidiary, has announced
today that Mr. Hou Song ("Mr. Hou") has resigned as an executive
director of Lansen, a member of the executive committee and as the
Chief Financial Officer of the Lansen group with effect on 20
October 2018 due to his decision to pursue his other career
opportunities. Mr. Hou has confirmed that he has no disagreement
with the board of Lansen and there is no matter that needs to be
bought to the attention of the shareholders of Lansen in relation
to his resignation.
The full text of the Lansen Announcement can be found at
http://www.hkexnews.hk/listedco/listconews/SEHK/2018/1012/LTN20181012367.pdf
and will also be made available at Announcements & Notices
section of Lansen's homepage at
http://holding.lansen.com.cn//en/newslist.aspx?NodeCode=10002000700050005
-Ends-
For further enquiries, please contact:
Cathay International Holdings Limited
Eric Siu (Finance Director) Tel: +852 2828 9289
Patrick Sung (Director and Controller)
Consilium Strategic Communications
Mary-Jane Elliott / Matthew Neal / Lindsey Neville Tel: +44 (0) 203 709 5702
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main
market listed investment holding company and an operator and
investor in the growing healthcare sector in the People's Republic
of China (the "PRC"). The Company and its subsidiaries
(collectively the "Group") aim to leverage on growth opportunities
in the strong and growing domestic demand for high quality
healthcare products in the PRC and build its portfolio companies
into market sector leaders with competitive edge. Cathay has
already demonstrated a strong track record of identifying high
growth potential investment opportunities in this area including:
Lansen, a leading specialty pharmaceutical company focused on
rheumatology and dermatology in the PRC; Haizi, a company engaged
in the manufacture, marketing and sale of inositol and its
by-product, di-calcium phosphate; Natural Dailyhealth, a company
engaged in production and sales of plant extracts for use as key
active ingredients in healthcare products; and Botai, a company
engaged in collagen products.
The Group employs approximately 1,800 people across the PRC,
including over 30 specialist corporate and business development
staff based at the holding company's offices in Hong Kong and
Shenzhen. Cathay also has a hotel investment. For more information
please visit the Company's website: www.cathay-intl.com.hk.
About Lansen
Lansen, whose shares are listed on the main board of the Hong
Kong Stock Exchange, is a 50.56% owned subsidiary of Cathay. Lansen
is engaged in the manufacture, distribution and development of
specialty prescription drugs for treatment of autoimmune disorder
in rheumatology and dermatology. Lansen is in the leading market
position in disease modifying anti-rheumatic drugs ("DMARDs") for
treatment of rheumatoid arthritis ("RA") in the PRC. Lansen has
established an extensive distribution network, covering more than
1,000 hospitals in four municipalities, 25 provinces and cities in
the PRC. For more information please visit the Lansen's website:
www.lansen.com.cn/en/index.aspx.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAKLLBFVBFLFBV
(END) Dow Jones Newswires
October 12, 2018 05:31 ET (09:31 GMT)
Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From Apr 2024 to May 2024
Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From May 2023 to May 2024